Search

Your search keyword '"Mogelvang R"' showing total 86 results

Search Constraints

Start Over You searched for: Author "Mogelvang R" Remove constraint Author: "Mogelvang R" Database MEDLINE Remove constraint Database: MEDLINE
86 results on '"Mogelvang R"'

Search Results

1. Increased preload and echocardiographic assessment of diastolic function.

2. Global myocardial oedema in resuscitated out-of-hospital cardiac arrest patients assessed by cardiac magnetic resonance: a pilot study.

3. Whole-cycle analysis of echocardiographic tissue Doppler velocities as a marker of biological age.

4. A new method to quantify left ventricular mass by 2D echocardiography.

5. Necropsy Validation of a Novel Method for Left Ventricular Mass Quantification in Porcine Transthoracic and Transdiaphragmal Echocardiography.

6. Layer-specific longitudinal strain detects transmural dysfunction in chronic severe aortic regurgitation before and after aortic valve surgery.

7. Measures of left atrial function predict incident heart failure in a low-risk general population: the Copenhagen City Heart Study.

8. Echocardiographic predictors of cardiovascular morbidity and mortality in women from the general population.

9. Impact of surgical aortic valve replacement on global and regional longitudinal strain across four flow gradient patterns of severe aortic stenosis.

10. The prognostic value of left atrial dyssynchrony measured by speckle tracking echocardiography in the general population.

11. Layer-Specific Strain Is Preload Dependent: Comparison between Speckle-Tracking Echocardiography and Cardiac Magnetic Resonance Feature-Tracking.

12. Accuracy and sensitivity of three-dimensional echocardiography to detect changes in right ventricular volumes: comparison study with cardiac magnetic resonance.

13. Myocardial performance index by tissue Doppler echocardiography predicts adverse events in patients with atrial fibrillation.

14. Level of Physical Activity, Left Ventricular Mass, Hypertension, and Prognosis.

15. Dose-Response Association Between Level of Physical Activity and Mortality in Normal, Elevated, and High Blood Pressure.

16. An echocardiographic substrate for dyspnea identifies high risk patients with type 2 diabetes.

17. The association between physical activity and cardiac performance is dependent on age: the Copenhagen City Heart Study.

18. Predictive value of echocardiography in Type 2 diabetes.

19. Semi-automated estimation of left ventricular ejection fraction by two-dimensional and three-dimensional echocardiography is feasible, time-efficient, and reproducible.

20. Burden of Uncontrolled Metabolic Risk Factors and Left Ventricular Structure and Function in Patients With Type 2 Diabetes Mellitus.

21. Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetes.

22. Prognostic Value of Echocardiography in Hypertensive Versus Nonhypertensive Participants From the General Population.

23. Diastolic dysfunction revisited: A new, feasible, and unambiguous echocardiographic classification predicts major cardiovascular events.

24. Left ventricular filling pressure by septal and lateral E/e' equally predict cardiovascular events in the general population.

25. Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome.

26. Insulin-Like Growth Factor Binding Protein 4 Fragments Provide Incremental Prognostic Information on Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction.

27. Global Longitudinal Strain by Echocardiography Predicts Long-Term Risk of Cardiovascular Morbidity and Mortality in a Low-Risk General Population: The Copenhagen City Heart Study.

28. Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function.

29. Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes.

30. Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics.

31. Regional Longitudinal Myocardial Deformation Provides Incremental Prognostic Information in Patients with ST-Segment Elevation Myocardial Infarction.

32. Plasma Neutrophil Gelatinase-Associated Lipocalin Reflects Both Inflammation and Kidney Function in Patients with Myocardial Infarction.

33. Cardiac Time Intervals by Tissue Doppler Imaging M-Mode: Normal Values and Association with Established Echocardiographic and Invasive Measures of Systolic and Diastolic Function.

34. Basal longitudinal strain predicts future aortic valve replacement in asymptomatic patients with aortic stenosis.

35. Cardiac Time Intervals Measured by Tissue Doppler Imaging M-mode: Association With Hypertension, Left Ventricular Geometry, and Future Ischemic Cardiovascular Diseases.

36. Plasma pro-brain natriuretic peptide and electrocardiographic changes in combination improve risk prediction in persons without known heart disease.

37. Tissue Doppler echocardiography predicts acute myocardial infarction, heart failure, and cardiovascular death in the general population.

38. Interplay Between Adiponectin and Pro-Atrial Natriuretic Peptide and Prognosis in Patients With ST-Segment Elevation Myocardial Infarction.

39. Tissue Velocities and Myocardial Deformation in Asymptomatic and Symptomatic Aortic Stenosis.

40. Systolic and Diastolic Function by Tissue Doppler Imaging Predicts Mortality in Patients with Atrial Fibrillation.

41. Prognostic value of cardiac time intervals measured by tissue Doppler imaging M-mode in the general population.

42. MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.

43. Association of ischemic heart disease to global and regional longitudinal strain in asymptomatic aortic stenosis.

44. Adiponectin, type 2 diabetes and cardiovascular risk.

45. Osteoprotegerin levels change during STEMI and reflect cardiac function.

46. Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction.

47. Electrocardiographic changes improve risk prediction in asymptomatic persons age 65 years or above without cardiovascular disease.

48. Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis.

49. LA emptying fraction improves diagnosis of paroxysmal AF after cryptogenic ischemic stroke: results from the SURPRISE study.

50. Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure.

Catalog

Books, media, physical & digital resources